| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-11 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
| mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
9e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.0002 |